PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 199 filers reported holding PDL BIOPHARMA INC in Q2 2013. The put-call ratio across all filers is 0.29 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $295,000 | -9.5% | 87,815 | -15.4% | 0.00% | -33.3% |
| Q2 2016 | $326,000 | +126.4% | 103,845 | +261.2% | 0.00% | – |
| Q3 2015 | $144,000 | -72.0% | 28,752 | -64.0% | 0.00% | -100.0% |
| Q2 2015 | $514,000 | +93.2% | 79,801 | +110.8% | 0.00% | +200.0% |
| Q1 2015 | $266,000 | -19.1% | 37,855 | -11.3% | 0.00% | -50.0% |
| Q4 2014 | $329,000 | +232.3% | 42,675 | +221.7% | 0.00% | +100.0% |
| Q3 2014 | $99,000 | -45.9% | 13,265 | -29.8% | 0.00% | -50.0% |
| Q2 2014 | $183,000 | -35.6% | 18,900 | -44.7% | 0.00% | 0.0% |
| Q1 2014 | $284,000 | -58.5% | 34,200 | -57.8% | 0.00% | -60.0% |
| Q4 2013 | $685,000 | -12.2% | 81,100 | -19.7% | 0.01% | +66.7% |
| Q2 2013 | $780,000 | – | 101,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nine Chapters Capital Management LLC | 119,700 | $254,000 | 0.43% |
| GSA CAPITAL PARTNERS LLP | 1,587,756 | $3,366,000 | 0.20% |
| AMERICAFIRST CAPITAL MANAGEMENT, LLC | 60,901 | $129,110,000 | 0.14% |
| Acrospire Investment Management LLC | 129,480 | $274,000 | 0.11% |
| SECOR Capital Advisors, LP | 410,323 | $870,000 | 0.11% |
| RBF Capital, LLC | 251,421 | $540,000 | 0.08% |
| Park West Asset Management LLC | 400,000 | $848,000 | 0.07% |
| MACKENZIE FINANCIAL CORP | 4,687,825 | $9,938,000 | 0.06% |
| CIGNA INVESTMENTS INC /NEW | 261,533 | $554,000,000 | 0.06% |
| ACADIAN ASSET MANAGEMENT LLC | 5,503,285 | $11,665,000 | 0.06% |